Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Personalized Medicine|December 1, 2025
How to treat BRAF mutant metastatic melanoma?Maria Cristina Sini, Milena Casula, Marina Pisano, et al.Pathologica|April 28, 2023
Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencingRenato Lobrano, Alessandra Manca, Maria Cristina Sini, et al.Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Genetic Instability Markers in CancerGiuseppe Palmieri, Milena Casula, Antonella Manca, et al.Critical Reviews in Oncology/Hematology|March 6, 2017
Long non-coding RNA CASC2 in human cancerGiuseppe Palmieri, Panagiotis Paliogiannis, Maria Cristina Sini, et al.Critical Reviews in Oncology/Hematology|July 8, 2024
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyondMaria Colombino, Milena Casula, Panagiotis Paliogiannis, et al.Experimental Hematology & Oncology|February 7, 2026
Mutation rates in main tumour driver genes predict prognosis in patients with superficial spreading or nodular primary melanoma: results from the CARAMEL study by the Italian Melanoma Intergroup (IMI)Maria Cristina Sini, Jerry Polesel, Sara Simi, et al.Melanoma Management|September 8, 2018
Epidemiological and genetic factors underlying melanoma development in ItalyGiuseppe Palmieri, Maria Colombino, Milena Casula, et al.Frontiers in Oncology|May 24, 2021
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy?Giuseppe Palmieri, Carla Maria Rozzo, Maria Colombino, et al.Cells|June 11, 2026
How Deeply Can mRNA Vaccines Affect the Responsiveness to Immune Checkpoint Inhibitors Through Changes in the Tumor Microenvironment? Evidence from MelanomaIvana Persico, Maria Grazia Doro, Laura Frogheri, et al.Oncotarget|March 2, 2018
Genetic alterations in main candidate genes during melanoma progressionMaria Cristina Sini, Valentina Doneddu, Panagiotis Paliogiannis, et al.Pageof 4